Tim Menzen honored by JPharmSci as Outstanding Early Career Scientist

2023/12/15

Tim Menzen honored by JPharmSci® as Outstanding Early Career Scientist

The Editorial Staff and the American Pharmacists Association have been recognizing outstanding outstanding early career scientists for publishing their most original and significant scientific findings in the Journal of Pharmaceutical Sciences.

One of these honored scientists is Tim Menzen, Chief Technology Officer at Coriolis. We warmly congratulate our colleague on this award.

Check out some of Tim's publications here:

Taking subvisible particle quantitation to the limit: Uncertainties and statistical challenges with ophthalmic products for intravitreal injection

Particles in Biopharmaceutical Formulations, Part 2

Characterization of Virus Particles and Submicron-Sized Particulate Impurities in Recombinant Adeno-Associated Virus Drug Product

Combining Machine Learning and Backgrounded Membrane Imaging

Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals

Access full article

News

2024/03/06

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.

News

2023/12/19

Modelling The Future Of Lyophilization

Coriolis experts Andrea Arsiccio and Brecht Vanbillemont publish article on lyophilization modelling in "the Medicine Maker".

News

2023/12/18

Coriolis donates to aid organizations

Coriolis spreads the Christmas spirit and donates to organizations that help people in need, fight for a healthy nature, or improve our society as a whole

News

2023/11/06

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

News

2023/10/16

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

News

2023/09/04

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.

News

2023/07/31

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

News

2023/07/28

Coriolis sponsors GFK sailing team

Coriolis sponsors GFK sailing team at H-Boat World Cup race from August 1-4, 2023, on Lake Garda in Italy. We keep our fingers crossed.

News

2023/07/18

Coriolis contributes to CNAT-M

Coriolis contributes to CNATM with drug product development expertise and formulation know-how to enable the transformation from innovative molecules towards drug products suitable for human application.

News

2023/07/05

Coriolis welcomes delegation from Japan

Last week we had the pleasure to welcome visitors from the Bio-Industry Division of the Japanese Ministry of Economy, Trade and Industry and from U-Medico at our headquarters in Martinsried.